









市场行情
/
股票
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

73.600USD

-0.810-1.09%

收盘 07/17, 16:00（美东）报价延迟15分钟

5.09B总市值

20.01市盈率 TTM



Lantheus Holdings Inc

73.600

-0.810-1.09%

概览公司财务

Lantheus Holdings, Inc. 是一家专注于放射性药物的公司，致力于提供科学成果，使临床医生能够发现、对抗和跟踪疾病，从而为患者带来治疗效果。该公司的产品分为三类：放射性药物肿瘤学、精准诊断和战略合作伙伴关系。放射性药物肿瘤学诊断和治疗可帮助医疗保健专业人员 (HCP) 发现、对抗和跟踪癌症，重点是前列腺癌。精准诊断产品可帮助 HCP 发现和跟踪疾病，重点是心脏病学。战略合作伙伴关系专注于通过使用生物标志物解决方案、数字解决方案和放射治疗平台实现精准医疗。其商业产品包括 PYLARIFY、DEFINITY、TechneLite 等。其产品线包括 B 淀粉样蛋白正电子发射断层扫描 (PET) 成像剂 NAV-4694，也称为 F18-氟呋喃醇。该公司拥有临床前资产，特别是 TROP2 和 DUNP19。

公司简介

公司代码LNTH

公司名称Lantheus Holdings Inc

上市日期Jun 25, 2015

成立日期2007

CEOMr. Brian A. Markison

员工数量808

证券类型Ordinary Share

年结日Jun 25

公司地址331 Treble Cove Road

城市NORTH BILLERICA

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编01862

电话19786718001

网址https://www.lantheus.com/

公司代码LNTH

上市日期Jun 25, 2015

成立日期2007

公司高管

名称

名称/职务

职务

持股

持股变动

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Ms. Amanda Morgan

Chief Commercial Officer

39.58K

+55.76%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+34.47%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+450.62%

Mr. Samuel R. (Sam) Leno

Independent Director

名称

名称/职务

职务

持股

持股变动

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Ms. Amanda Morgan

Chief Commercial Officer

39.58K

+55.76%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

收入明细

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

暂无数据

业务

地区

业务USD

名称

营收

占比

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

股东统计

更新时间: 5月14日周三

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.27%

The Vanguard Group, Inc.

10.10%

Janus Henderson Investors

9.05%

Farallon Capital Management, L.L.C.

8.71%

State Street Global Advisors (US)

3.81%

Other

57.07%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.27%

The Vanguard Group, Inc.

10.10%

Janus Henderson Investors

9.05%

Farallon Capital Management, L.L.C.

8.71%

State Street Global Advisors (US)

3.81%

Other

57.07%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

53.47%

Investment Advisor

43.79%

Hedge Fund

11.55%

Research Firm

3.19%

Individual Investor

2.27%

Pension Fund

1.94%

Bank and Trust

1.35%

Sovereign Wealth Fund

0.57%

Family Office

0.09%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

1027

81.92M

118.40%

-3.35M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

2023Q2

790

72.85M

106.61%

-3.94M

2023Q1

733

71.94M

105.47%

-6.73M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.79M

11.27%

+17.69K

+0.23%

Mar 31, 2025

The Vanguard Group, Inc.

6.99M

10.1%

-242.63K

-3.36%

Mar 31, 2025

Janus Henderson Investors

6.26M

9.05%

-252.58K

-3.88%

May 30, 2025

Farallon Capital Management, L.L.C.

6.02M

8.71%

+707.00K

+13.30%

Mar 31, 2025

State Street Global Advisors (US)

2.64M

3.81%

-4.26K

-0.16%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.17M

3.14%

+148.84K

+7.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.78M

2.57%

+94.57K

+5.62%

Mar 31, 2025

Westfield Capital Management Company, L.P.

1.59M

2.3%

+34.05K

+2.19%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.41M

2.04%

-96.91K

-6.42%

Mar 31, 2025

Reinhart Partners, LLC

1.21M

1.74%

-160.93K

-11.77%

Mar 31, 2025

持股ETF

更新时间: 7月6日周日

机构名称

占比

Harbor Health Care ETF

2.88%

Invesco S&P MidCap 400 GARP ETF

2.64%

Invesco Dorsey Wright Healthcare Momentum ETF

2.28%

SPDR S&P Health Care Equipment ETF

1.83%

Fidelity Stocks for Inflation ETF

1.32%

Janus Henderson US Sustainable Equity ETF

1.26%

Invesco S&P MidCap 400 Pure Growth ETF

1.06%

First Trust Small Cap US Equity Select ETF

Astoria US Quality Kings ETF

0.78%

VictoryShares Free Cash Flow Growth ETF

0.74%

Harbor Health Care ETF

占比2.88%

Invesco S&P MidCap 400 GARP ETF

占比2.64%

Invesco Dorsey Wright Healthcare Momentum ETF

占比2.28%

SPDR S&P Health Care Equipment ETF

占比1.83%

Fidelity Stocks for Inflation ETF

占比1.32%

Janus Henderson US Sustainable Equity ETF

占比1.26%

Invesco S&P MidCap 400 Pure Growth ETF

占比1.06%

First Trust Small Cap US Equity Select ETF

占比1%

Astoria US Quality Kings ETF

占比0.78%

VictoryShares Free Cash Flow Growth ETF

占比0.74%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

KeyAI

